Detalles de la búsqueda
1.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet;
400(10358): 1117-1129, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36099927
2.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet;
395(10236): 1558-1568, 2020 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32416781
3.
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study.
J Geriatr Oncol;
14(8): 101638, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776611
Resultados
1 -
3
de 3
1
Próxima >
>>